BELSOMRA (suvorexant) is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.
 
DOSAGE AND ADMINISTRATION
Dosing Information
Use the lowest dose effective for the patient.
The recommended dose for BELSOMRA is 10 mg, taken no more than once per night and within 30 minutes of going to bed, with at least 7 hours remaining before the planned time of awakening. If the 10 mg dose is well-tolerated but not effective, the dose can be increased. The maximum recommended dose of BELSOMRA is 20 mg once daily.
 
SIDE EFFECTS
 
Diarrhea
Dry
mouth
Nervous
System
Disorders
Headache
Somnolence
Dizziness
Psychiatric Disorders
Abnormal
dreams
Cough